1) Olesen M, Eriksson S, Bohr J, et al. Microscopic colitis: a common diarrhoeal disease. An epidemiological study in Orebro, Sweden, 1993-1998. Gut. 2004; 53: 346-50
|
|
|
2) Pardi DS, Loftus EV Jr, Smyrk TC, et al. The epidemiology of microscopic colitis: a population based study in Olmsted County, Minnesota. Gut. 2007; 56: 504-8
|
|
|
3) Williams JJ, Kaplan GG, Makhija S, et al. Microscopic colitis-defining incidence rates and risk factors: a population-based study. Clin Gastroenterol Hepatol. 2008; 6: 35-40
|
|
|
4) Fernández-Bañares F, Salas A, Esteve M, et al. Evolution of the incidence of collagenous colitis and lymphocytic colitis in Terrassa, Spain: a population-based study. Inflamm Bowel Dis. 2011; 17: 1015-20
|
|
|
5) 堀田欣一, 小山恒男, 宮田佳典, 他. 慢性下痢症におけるMicroscopic Colitisの頻度. 本邦における大腸内視鏡下ランダム生検を用いた遡及的研究結果. 消化器内視鏡.. 2008; 20: 1357-61
|
|
|
6) Wildt S, Rumessen JJ, Csillag C, et al. Cyclooxygenase-2 immunoreactivity in collagenous colitis. APMIS. 2009; 117: 500-6
|
|
|
7) Wagner M, Lampinen M, Sangfelt P, et al. Budesonide treatment of patients with collagenous colitis restores normal eosinophil and T-cell activity in the colon. Inflamm Bowel Dis. 2010; 16: 1118-26
|
|
|
8) Jöhrens K, Grünbaum M, Anagnostopoulos I. Differences in the T-bet and GATA-3 expression patterns between lymphocytic colitis and coeliac disease. Virchows Arch. 2010; 457: 451-6
|
|
|
9) El-Salhy M, Lomholt-Beck B, Gundersen TD. High chromogranin A cell density in the colon of patients with lymphocytic colitis. Mol Med Report. 2011; 4: 603-5
|
|
|
10) Gunther U, Bateman AC, Beattie RM, et al. Connective tissue growth factor expression is increased in collagenous colitis and coeliac disease. Histopathology. 2010; 57: 427-35
|
|
|
11) Barta Z, Zold E, Nagy A, et al. Celiac disease and microscopic colitis: A report of 4 cases. World J Gastroenterol. 2011; 17: 2150-4
|
|
|
12) Stewart M, Andrews CN, Urbanski S, et al. The association of coeliac disease and microscopic colitis: a large population-based study. Aliment Pharmacol Ther. 2011; 33: 1340-9
|
|
|
13) Green PH, Yang J, Cheng J, et al. An association between microscopic colitis and celiac disease. Clin Gastroenterol Hepatol. 2009; 7: 1210-6
|
|
|
14) Madisch A, Hellmig S, Schreiber S, et al. Allelic variation of the matrix metalloproteinase-9 gene is associated with collagenous colitis. Inflamm Bowel Dis. 2011 [Epub ahead of print]
|
|
|
15) Lakatos G, Sipos F, Miheller P, et al. The behavior of matrix metalloproteinase-9 in lymphocytic colitis, collagenous colitis and ulcerative colitis. Pathol Oncol Res. 2011 [Epub ahead of print]
|
|
|
16) Münch A, Söderholm JD, Ost A, et al. Increased transmucosal uptake of E. coli K12 in collagenous colitis persists after budesonide treatment. Am J Gastroenterol. 2009; 104: 679-85
|
|
|
17) Münch A, Söderholm JD, Ost A, et al. Low levels of bile acids increase bacterial uptake in colonic biopsies from patients with collagenous colitis in remission. Aliment Pharmacol Ther. 2011; 33: 954-60
|
|
|
18) Umeno J, Matsumoto T, Nakamura S, et al. Linear mucosal defect may be characteristic of lansoprazole-associated collagenous colitis. Gastrointest Endosc. 2008; 67: 1185-91
|
|
|
19) 松原亜季子, 九嶋亮治, 柿木里枝, 他. Collagenous colitis 日本人症例の特徴. 病理と臨床. 2008; 26: 823-32
|
|
|
20) Chiba M, Sugawara T, Tozawa H, et al. Lansoprazole-associated collagenous colitis: diffuse mucosal cloudiness mimicking ulcerative colitis. World J Gastroenterol. 2009; 15: 2166-9
|
|
|
21) Yusuke H, Jun T, Naotaka M, et al. Lansoprazole-associated collagenous colitis: unique presentation, similar to ischemic colitis. Endoscopy. 2009; 41 Suppl 2: E281-2
|
|
|
22) 関岡敏夫, 齊藤昌彦, 田中俊樹, 他. 腹膜炎で発症し, 大腸内視鏡検査にて地割れ潰瘍を呈したランソプラゾール関連膠原線維性大腸炎の1例. 日本大腸肛門病学会雑誌. 2009; 62: 527-33
|
|
|
23) 九嶋亮治, 松原亜季子. Collagenous colitisの臨床病理学的特徴, 病態発生と鑑別診断. 胃と腸. 2009; 44: 1955-65
|
|
|
24) 山崎健路, 華井頼子, 森 良雄, 他. 縦走潰瘍を伴ったcollagenous colitisの1例. 胃と腸. 2009; 44: 2041-8
|
|
|
25) 清水誠治, 南 竜城, 廣瀬亮平, 他. 興味深い内視鏡像を呈したcollagenous colitisの1例. 胃と腸. 2009; 44: 2050-6
|
|
|
26) 斉藤裕輔, 小澤賢一郎, 富永素矢, 他. ステロイド投与が必要であったlansoplazole-associated collagenous colitisの1例. 胃と腸. 2009; 44: 2057-66
|
|
|
27) 石原裕士, 松井敏幸, 原岡誠司, 他. Collagenous colitisの16例 内視鏡像と組織像との関連. 胃と腸. 2009; 44: 1983-94
|
|
|
28) 大川清孝, 上田 渉, 佐野弘治, 他. Collagenous colitisの鑑別診断と治療. 胃と腸. 2009; 44: 2006-17
|
|
|
29) Nomura E, Kagaya H, Uchimi K, et al. Linear mucosal defects: a characteristic endoscopic finding of lansoprazole-associated collagenous colitis. Endoscopy. 2010; 42 Suppl 2: E9-10
|
|
|
30) Fernández-Bañares F, Esteve M, Espinos JC, et al. Drug consumption and the risk of microscopic colitis. Am J Gastroenterol. 2007; 102: 324-30
|
|
|
31) 梅野淳嗣, 松本主之, 中村昌太郎, 他. 薬剤起因性collagenous colitis ランソプラゾールに関連した内視鏡的特徴を中心に. 胃と腸. 2009; 44: 1973-82
|
|
|
32) Wilcox GM, Mattia AR. Microscopic colitis associated with omeprazole and esomeprazole exposure. J Clin Gastroenterol. 2009; 43: 551-3
|
|
|
33) Keszthelyi D, Jansen SV, Schouten GA, et al. Proton pump inhibitor use is associated with an increased risk for microscopic colitis: a case-control study. Aliment Pharmacol Ther. 2010; 32: 1124-8
|
|
|
34) Sano S, Yamagami K, Tanaka A, et al. A unique case of collagenous colitis presenting as protein-losing enteropathy successfully treated with prednisolone. World J Gastroenterol. 2008; 14: 6083-6
|
|
|
35) Cuoco L, Bertoncello V, Salvagnini M. Colonic perforation after colonoscopy in patients with collagenous colitis. Am J Gastroenterol. 2009; 104: 1846-7
|
|
|
36) Allende DS, Taylor SL, Bronner MP. Colonic perforation as a complication of collagenous colitis in a series of 12 patients. Am J Gastroenterol. 2008; 103: 2598-604
|
|
|
37) Bains S, Lloyd GM, Sutton CD, et al. A case of toxic megacolon in a patient with collagenous colitis. Tech Coloproctol. 2009; 13: 165-6
|
|
|
38) Hjortswang H, Tysk C, Bohr J, et al. Defining clinical criteria for clinical remission and disease activity in collagenous colitis. Inflamm Bowel Dis. 2009; 15: 1875-81
|
|
|
39) Lorinczy K, Lakatos G, Müllner K, et al. Low bone mass in microscopic colitis. BMC Gastroenterol. 2011; 11: 58
|
|
|
40) Dunzendorfer T, Wilkins S, Johnson R. Mucosal tear in collagenous colitis. Clin Gastroenterol Hepatol. 2009; 7: e57
|
|
|
41) Couto G, Bispo M, Barreiro P, et al. Unique endoscopy findings in collagenous colitis. Gastrointest Endosc. 2009; 69: 1186-8
|
|
|
42) van Velden R, Snieders I, Quispel R. Image of the month. Tearing of the colon in a patient with collagenous colitis during colonoscopy. Clin Gastroenterol Hepatol. 2010; 8: A28
|
|
|
43) Koulaouzidis A. Mucosal scars in collagenous colitis. Gastrointest Endosc. 2010; 71: 221-2
|
|
|
44) Hashimoto Y, Endo Y, Kuroki Y, et al. Collagenous colitis with unique colonoscopic findings. Endoscopy. 2008; 40 Suppl 2: E162
|
|
|
45) Kiesslich R, Goetz M, Neurath MF. Confocal laser endomicroscopy for gastrointestinal diseases. Gastrointest Endosc Clin North Am. 2008; 18: 451-66
|
|
|
46) Zambelli A, Villanacci V, Buscarini E, et al. Collagenous colitis: a case series with confocal laser microscopy and histology correlation. Endoscopy. 2008; 40: 606-8
|
|
|
47) Shale MJ, Walters JR, Westaby D. Adequacy of flexible sigmoidoscopy with biopsy for diarrhea in patients under age 50 without features of proximal disease. Gastrointest Endosc. 2011; 73: 757-64
|
|
|
48) Fernández-Bañares F, Salas A, Forne M, et al. Incidence of collagenous and lymphocytic colitis: a 5-year population-based study. Am J Gastroenterol. 1999; 94: 418-23
|
|
|
49) Zins BJ, Tremaine WJ, Carpenter HA. Collagenous colitis: mucosal biopsies and association with fecal leukocytes. Mayo Clin Proc. 1995; 70: 430-3
|
|
|
50) Baert F, Schmit A, D'Haens G, et al. Budesonide in collagenous colitis: a double-blind placebo-controlled trial with histologic follow-up. Gastroenterology. 2002; 122: 20-5
|
|
|
51) Miehlke S, Heymer P, Bethke B, et al. Budesonide treatment for collagenous colitis: a randomized, double-blind, placebo-controlled, multicenter trial. Gastroenterology. 2002; 123: 978-84
|
|
|
52) Bonderup OK, Hansen JB, Birket-Smith L, et al. Budesonide treatment of collagenous colitis: a randomised, double blind, placebo controlled trial with morphometric analysis. Gut. 2003; 52: 248-51
|
|
|
53) Chande N, MacDonald JK, McDonald JW. Interventions for treating microscopic colitis: a Cochrane Inflammatory Bowel Disease and Functional Bowel Disorders Review Group systematic review of randomized trials. Am J Gastroenterol. 2009; 104: 235-41
|
|
|
54) Miehlke S, Madisch A, Karimi D, et al. Budesonide is effective in treating lymphocytic colitis: a randomized double-blind placebo-controlled study. Gastroenterology. 2009; 136: 2092-100
|
|
|
55) Miehlke S, Madisch A, Bethke B, et al. Oral budesonide for maintenance treatment of collagenous colitis: a randomized, double-blind, placebo-controlled trial. Gastroenterology. 2008; 135: 1510-6
|
|
|
56) Bonderup OK, Hansen JB, Teglbjaerg PS, et al. Long-term budesonide treatment of collagenous colitis: a randomised, double-blind, placebo-controlled trial. Gut. 2009; 58: 68-72
|
|
|